Chemotherapy induced neutropenia trang 1 tải miễn phí từ TAILIEUCHUNG

"Chemotherapy induced neutropenia" trang 1 - tải miễn phí từ Tailieuchung

Febrile neutropenia (FN) occurrence outside of clinical trials: Occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinational study

Febrile neutropenia (FN) occurrence outside of clinical trials: Occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinational study

8 32 1

Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: Results of a randomized, double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy

Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: Results of a randomized, double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy

10 66 1

Timing of chemotherapy-induced neutropenia predicts prognosis in metastatic colon cancer patients: A retrospective study in mFOLFOX6 -treated patients

Timing of chemotherapy-induced neutropenia predicts prognosis in metastatic colon cancer patients: A retrospective study in mFOLFOX6 -treated patients

8 25 1

$Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: A cohort study$

Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: A cohort study

7 58 1

Study design: Two long-term observational studies of the biosimilar filgrastim Nivestim™ (Hospira filgrastim) in the treatment and prevention of chemotherapy-induced neutropenia

Study design: Two long-term observational studies of the biosimilar filgrastim Nivestim™ (Hospira filgrastim) in the treatment and prevention of chemotherapy-induced neutropenia

9 28 1

Oxaliplatin-versus cisplatin-based regimens for elderly individuals with advanced gastric cancer: A retrospective cohort study

Oxaliplatin-versus cisplatin-based regimens for elderly individuals with advanced gastric cancer: A retrospective cohort study

9 9 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.